Learn More
OBJECTIVE Average length of inpatient stay at psychiatric hospitals in Japan has been consistently longer than that in any other developed country, and was 330 days in 1996. Although some reforms have been implemented with the intention of decreasing length of stay (LOS), appreciable reductions have not been achieved. The present study examined hospital(More)
Yokukansan (YKS) is used frequently against behavioral and psychological symptoms of dementia (BPSD) together with donepezil in patients with Alzheimer's disease (AD). Here, we investigated the efficacy and safety of YKS in patients with AD in a non-blinded, randomized, parallel-group comparison study. Patients who had at least one symptom score of four or(More)
OBJECTIVE There is evidence that the stigma surrounding mental illness may be greater in Japan than elsewhere. However, few Japanese studies have focused on self-stigma (the internalization of social stigma), and few interventions to reduce self-stigma exist. To remedy this deficiency, we evaluated the efficacy of group cognitive-behavioral therapy (CBT) in(More)
In Alzheimer's-type dementia, significant nerve cell degeneration is seen in the medial temporal lobe, including the hippocampal region, and in the temporoparietal association area. As symptoms progress, impairments in various behaviours begin to occur in daily life. In particular, higher brain dysfunction, including parietal association area dysfunction,(More)
  • 1